Reference: GILA/PB/C03/2608
Company stage: Series C
Seat classification: Contractually independent, non-executive private-company board seat; final statutory classification to be confirmed before appointment
Primary board geography: Bengaluru and Hyderabad with global customer operations
Meeting pattern: Seven boards, quarterly AI/Technology Risk Committee and two model assurance reviews
Status: Confidential retained-search specification; client identity only after conflict pre-clearance and NDA.
Anonymised company context
An enterprise AI company providing speech recognition, translation, summarisation and agent-assist products for contact centres, banks, telecom companies and public-service organisations across Indian languages.
The company has raised USD 80–120 million and reports recurring platform revenue plus implementation and usage fees. It uses proprietary and third-party foundation models, customer recordings and a distributed annotation workforce.
Calibrated market hint: Indian-language depth, twin engineering hubs and contact-centre focus point to a small enterprise-AI cohort while leaving identity protected. Candidates must treat any inference as confidential and disclose it only for conflict screening.
Why the seat exists now
The board needs independence on what the product can safely claim and which customers or use cases require human control. Accuracy averages can hide failure by language, accent, demographic group and consequence. Workforce and data provenance are as material as model quality.
At Series C, the company should be building option value: a later IPO, strategic transaction or continued private growth must all remain credible. That requires committee-grade oversight, disclosure-controlled KPIs, a clean group structure, mature risk ownership and decisions that serve the company rather than the timetable of any one shareholder.
Board design, authority and boundaries
Contractually independent director; Chair of voluntary AI, Data & Technology Risk Committee and member of Audit for KPI, revenue and capitalised-development matters.
The appointee is expected to ask for evidence, frame choices, record dissent and hold management accountable. The appointee is not a part-time executive, broker, operating consultant, fundraiser or representative of the investor who proposed the name. Management remains responsible for execution.
Strategic charter — first 18 months
- Approve a risk-tier framework by use case, customer, decision consequence and degree of automation
- Define release, rollback, human-review and prohibited-use requirements
- Validate accuracy, hallucination, latency and harmful-output performance by language and cohort, not blended average
- Map training-data, customer-recording, licence, consent and deletion rights
- Govern annotator employment/vendor conditions, confidentiality, quality and exposure to harmful content
- Review third-party model concentration, change notifications, security and exit options
- Reconcile ARR, usage, bookings, implementation and GPU/cloud cost to controlled financial metrics
- Prepare the company for product-liability, AI-regulation, customer diligence and eventual public-market disclosure without turning the director into a model reviewer
Decisions likely to reach this director
- Whether an accuracy level is sufficient for a bank or public-service use case
- Whether a third-party model change requires customer suspension
- Whether a fast-growing implementation should be counted as recurring product revenue
These are not hypothetical interview prompts. They describe the type of decision on which the board expects an independent company-interest view, including the ability to say “not yet,” “only with conditions,” or “stop.”
Candidate market — evidence, not labels
Essential
- AI product-risk, enterprise software, language technology, contact-centre operations, privacy or cyber leader with board judgement
- Ability to translate model performance into customer harm and commercial decisions
- Recurring/usage economics
- Independence from model vendors and investors
Particularly valuable
- Multilingual evaluation, responsible AI, data rights, human-factors or critical enterprise deployment
- Major AI incident or model rollback
- Software IPO or global customer assurance
The search is deliberately open to former operators, founders, functional leaders, investors with genuine board experience, regulators, academics with operating relevance and experienced directors. Prior service on a listed board is useful but not a proxy for judgement.
IICA Databank and legal eligibility position
This search does not impose IICA Independent Directors Databank registration or the proficiency test as a blanket application gate. The disclosed company is presently private, and the seat is designed as a contractually independent non-executive board role. Before appointment, counsel and the Company Secretary will determine whether the company’s actual legal form, public-company status, holding/subsidiary relationships, borrowing or other facts trigger any statutory independent-director requirement. If the seat is later redesignated as a statutory Independent Director role during conversion or IPO preparation, the appointee must complete every then-applicable requirement before that redesignation.
All candidates must still have a valid DIN before appointment, complete required KYC/consent/disclosures, be free of Section 164 disqualification, remain within applicable Section 165 limits, and satisfy the Articles, shareholders’ agreement, investor consent rights and any sector-specific fit-and-proper rules. “Not required to be in the Databank today” does not mean “unregulated” or “low-liability.”
Independence and conflict screens
Relationships with model/cloud providers, annotators, customers, investors, academics licensing data, competitors or government buyers; paid benchmarking of current models; ownership of disputed datasets.
GILA will map pecuniary, advisory, investment, family, customer, supplier, competitor and investor relationships across the look-back period agreed with counsel. A fund nominee is not automatically independent; a well-known listed-company director is not automatically suitable; and a small equity holding is not automatically harmless. Substance and perception will both be assessed.
Downside diligence offered to the candidate
Before consent, the shortlisted candidate will receive under NDA: the cap table and side letters; Articles and shareholders’ agreement; last six board packs and minutes; cash/runway case; material contracts; regulatory, litigation, IP and related-party schedules; insurance policies; founder/KMP employment and equity terms; latest audit or financial review; whistleblower and incident summary; and a written statement of the expected board/committee classification. The candidate may request independent legal advice through an agreed protocol.
First-year evidence of success
The target is a diligence-ready, committee-ready company with auditable operating claims and strategic options that have not been damaged by avoidable governance debt. For this mandate, the board will look for:
- Every material use case has risk tier and accountable owner
- Model claims are cohort-tested
- Data and workforce provenance withstand diligence
- ARR and cost-to-serve metrics reconcile to contracts and infrastructure
Commitment, economics and protection
- Expected commitment: 24–32 days annually, including model-event availability.
- Commercial terms: Three-year term. Fixed cash fee and committee fee; no vendor referral or dataset licensing economics. Equity separately reviewed. Cyber, privacy, professional/product and D&O cover required.
- Minimum protection: a written appointment letter, information and inspection rights, minuting of dissent, a deed of indemnity to the extent legally available, appropriate D&O with advancement and run-off, and access to independent advice.
- No hidden commercial role: no placement fee, sales referral, government liaison, customer introduction or consulting retainer is implied by the board appointment. Any separate engagement would require prior board approval, conflict review and clear disclosure; in many cases it will be prohibited.
Search and appointment process
Conflict pre-clearance → founder and lead-investor conversations held separately → GILA/SYMPHONY™ board-fit assessment → live mandate case → cap-table/SHA and board-pack diligence under NDA → references including one from a difficult company period → joint founder/investor/NRC session → legal, reputation and independence checks → board/shareholder appointment under the constitutional documents.